A Mini Review on New Drugs Approved in 2021

Authors

  • Akash Agnihotri Medical Pharmacology, Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India. Author
  • Saravana kumar Ramasubbu Senior Resident, Pharmacology, Department of Pharmacology, All India Institute of Medical Sciences, Delhi, India. Author
  • Subhash Samanta Pharmacology, Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India. Author
  • Biswadeep Das Additional Professor, Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India. Author
  • Manjunath Bidarolli Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India. Author

DOI:

https://doi.org/10.47363/JJCMR/2022(2)131

Keywords:

New drugs, FDA-approved drugs, Novel drugs 2021

Abstract

In 2021, the US Food and Drug Administration approved 50 novel drugs. Twenty three of the 50 (46%) drugs were categorized as orphan drug, and 9 of the 50 (18%) were approved under accelerated approval. This review includes a summary of the novel drugs approved by the US Food and Drug Administration in 2021.

Author Biographies

  • Akash Agnihotri, Medical Pharmacology, Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

    Akash Agnihotri, Medical Pharmacology, Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

  • Saravana kumar Ramasubbu, Senior Resident, Pharmacology, Department of Pharmacology, All India Institute of Medical Sciences, Delhi, India.

    Saravana kumar Ramasubbu, Senior Resident, Pharmacology, Department of Pharmacology, All India Institute of Medical Sciences, Delhi, India.

  • Subhash Samanta, Pharmacology, Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

    Subhash Samanta, Pharmacology, Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

  • Biswadeep Das, Additional Professor, Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

    Biswadeep Das, Additional Professor, Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

  • Manjunath Bidarolli, Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

    Manjunath Bidarolli, Department of Pharmacology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Downloads

Published

2025-12-05

Issue

Vol. 2 No. 2 (2022): Volume 2 Issue 2

Section

Articles